64. EORTC-1203: Integration of trastuzumab, with or without pertuzumab, into perioperative chemotherapy of HER-2 positive stomach cancer: INNOVATION EudraCT number 2014-000722-38; NCT02205047. Issue 9 (September 2016) - Wagner, A.D.; Kang, Y.K.; Van Dieren, J.; Mauer, M.; Grabsch, H.; Caballero, C.; Kataoka, K.; Atasoy, A.; Cho, J.Y.; Mohler, M.; Roth, A.; Salto-Tellez, M.; et al.